A novel mRNA cancer vaccine helps cut the chances of melanoma tumor recurrence in major study

CBC - Oct 23, 2026

A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck.

Read full article

MORE NEWS

In The Headline

In The Headline sought to bring professionalism back into journalism, bringing you only the most exclusive and the most impactive news from all over the globe.